![]() |
市場調查報告書
商品編碼
1904356
靜脈支架市場規模、佔有率和成長分析(按技術、產品、植入方法、材質、支架設計、支架植入部位和地區分類)-2026-2033年產業預測Venous Stents Market Size, Share, and Growth Analysis, By Technology, By Product, By Mode Of Delivery, By Material, By Stent Design, By Placement of Stent, By Region - Industry Forecast 2026-2033 |
||||||
預計到 2024 年,全球靜脈支架市場規模將達到 109.8 億美元,到 2025 年將達到 116 億美元,到 2033 年將達到 179.3 億美元,預測期(2026-2033 年)的複合年成長率為 5.6%。
由於靜脈疾病盛行率不斷上升和人口老化,全球靜脈支架市場正經歷強勁成長。越來越多的患者尋求有效治療慢性靜脈功能不全和深層靜脈栓塞症等疾病,推動了對支架治療解決方案的需求。支架技術的進步,包括創新設計和材料的運用,有助於改善臨床療效,進一步促進市場成長。此外,患者和醫療專業人員對靜脈疾病的認知不斷提高,也顯著推動了全球靜脈支架市場的整體擴張,預示著未來發展和市場動態的良好前景。
全球靜脈支架市場促進因素
由於慢性靜脈疾病(包括血栓後症候群和深層靜脈栓塞症)的盛行率不斷上升,全球靜脈支架市場正經歷顯著成長。這些疾病通常需要介入治療來恢復血流並減輕長期併發症。此外,診斷能力的提高以及老齡化社會對血管健康的日益重視,正在推動已開發國家和開發中國家醫療保健市場對靜脈支架的需求。隨著越來越多的患者尋求有效的靜脈疾病治療方法,對患者照護和創新醫療解決方案的日益重視預計將推動該行業的持續擴張。
限制全球靜脈支架市場的因素
全球靜脈支架市場面臨許多限制因素,其中高成本主要體現在器材本身、術前影像檢查和專業服務等。這些費用可能會限制病患的就醫機會,尤其是在健保報銷體係不完善的地區。此外,這種經濟負擔往往也阻礙了診所和醫院採用先進的支架技術。在價格敏感型市場和公共醫療體系中,如果沒有擴大保險覆蓋範圍和提高營運效率,就難以實現支架技術的廣泛應用。這些因素共同阻礙了支架技術的普及,並限制了市場的整體成長潛力。
全球靜脈支架市場趨勢
全球靜脈支架市場正經歷著向微創治療方案的顯著轉變,其驅動力在於縮短恢復時間、降低手術風險並提高病患滿意度。隨著醫療系統優先考慮門診和當日手術方案,對相容這些創新技術的靜脈支架的需求日益成長,尤其是在髂股靜脈阻塞等病例中。這種轉變正在影響醫院的採購模式,並促使製造商重新設計產品以適應不斷變化的靜脈治療格局,最終改善全球醫療機構的治療效果和病患體驗。
Global Venous Stents Market size was valued at USD 10.98 Billion in 2024 and is poised to grow from USD 11.6 Billion in 2025 to USD 17.93 Billion by 2033, growing at a CAGR of 5.6% during the forecast period (2026-2033).
The global venous stents market is experiencing robust growth, fueled by a rise in venous disease prevalence and an expanding aging population. With a growing number of patients seeking efficient treatment for conditions like chronic venous insufficiency and deep vein thrombosis, the demand for stenting solutions is on the rise. Advances in stent technology, including innovative designs and materials, are contributing to improved clinical outcomes, further bolstering market growth. Additionally, heightened awareness among patients and healthcare providers regarding venous diseases is significantly enhancing the overall expansion of the global venous stents sector, indicating a promising outlook for future developments and market dynamics.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Venous Stents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Venous Stents Market Segments Analysis
Global Venous Stents Market is segmented by Technology, Product, Mode Of Delivery, Material, Stent Design, Placement of Stent, Indication, End-user and region. Based on Technology, the market is segmented into Drug-Eluting Stents, Bare Metal Stents, Covered Stents and Bioabsorbable Stents. Based on Product, the market is segmented into Coronary Stents, Peripheral Stents and Evar Stent Grafts. Based on Mode Of Delivery, the market is segmented into Balloon-Expandable Stents and Self-Expanding Stents. Based on Material, the market is segmented into Metallic Materials and Polymeric Materials. Based on Stent Design, the market is segmented into Braided, Laser-cut, Open-cell and Closed-cell. Based on Placement of Stent, the market is segmented into Lower Limbs, Thorax, Abdomen and Upper Limbs. Based on Indication, the market is segmented into Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Nutcracker Syndrome, Hemodialysis / Arteriovenous Fistulae and Others. Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers, Specialty Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Venous Stents Market
The global venous stents market is experiencing significant growth due to the rising prevalence of chronic venous conditions, including post-thrombotic syndrome and deep vein thrombosis. These conditions often necessitate interventional therapies aimed at restoring blood flow and mitigating long-term complications. Additionally, there is growing demand for venous stents across both established and developing healthcare markets, driven by improved diagnostic capabilities and heightened awareness of vascular health among aging populations. As more individuals seek effective treatment options for venous disorders, the industry is poised for continuous expansion, reflecting an increased focus on patient care and innovative medical solutions.
Restraints in the Global Venous Stents Market
The Global Venous Stents market faces significant restraints primarily due to the high costs associated with devices, pre-procedure imaging, and specialized services. These expenses can limit patient access, especially in areas where reimbursement systems are underdeveloped. Furthermore, the financial burden often discourages clinics and hospitals from adopting advanced stent technologies. In price-sensitive markets and public healthcare systems, achieving penetration can prove difficult unless there is an improvement in insurance coverage and operational efficiencies. These factors collectively hinder broader adoption and limit the market's overall growth potential.
Market Trends of the Global Venous Stents Market
The Global Venous Stents market is experiencing a significant trend towards less invasive treatment options, driven by a pursuit of shorter recovery times, reduced operational risks, and enhanced patient satisfaction. As healthcare systems increasingly prioritize outpatient care and day surgery initiatives, there is a rising demand for venous stents that are compatible with these innovative techniques, particularly for conditions such as iliofemoral vein obstruction. This shift is influencing hospital purchasing patterns and inspiring manufacturers to redesign products to align with the evolving landscape of venous interventions, ultimately aiming to improve treatment outcomes and patient experiences across health settings worldwide.